Opportunities
Search

Buyer: Jihočeský kraj | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-07-08

Buyer: Régie de l'Eau Bordeaux Métropole | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-08

Buyer: Régie de l'Eau Bordeaux Métropole | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-08

Buyer: Régie de l'Eau Bordeaux Métropole | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-08

Buyer: Eisenbahn-Bundesamt | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-08

Buyer: Public Health Institution General Hospital Bar | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-08

Buyer: ENSM. | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-08

Buyer: Körperschaften des öffentlichen Rechts auf Bundesebene | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-08

Buyer: Przedsiębiorstwo Komunikacji Miejskiej sp. z o.o. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-08

Buyer: COMMUNAUTE DE COMMUNES DU VEXIN THELLE | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-07-08

Buyer: Trenitalia S.p.A. Direzione Logistica Industriale Acquisti Tecnici | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-08

Buyer: Stichting Bibliotheken Eemland | Coöperatie het Eemhuis | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-08

Buyer: Haute Autorité de Santé | Notice type: cn-standard | Procedure: oth-single | Contract: services | Deadline: 2026-07-08

Buyer: R.E.T. N.V. | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-07-08

Buyer: SPEEH HIDROELECTRICA SA | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-07-08

Buyer: Stedin | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-08

Buyer: Gemeente Breda | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-08

Buyer: Ministerstvo obrany | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-07-08

Buyer: Bundeswehr-Dienstleistungszentrum Landsberg am Lech | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-07-08

Buyer: Miejskie Przedsiębiorstwo Wodociągów i Kanalizacji S.A. | Notice type: pin-rtl | Contract: supplies | Deadline: 2026-07-08

The Center for Inherited Disease Research (CIDR) high-throughput genotyping, sequencing and supporting statistical genetics services are designed to aid the identification of genes or genetic modifications that contribute to human health and disease or to enhance existing collections of well-phenotyped specimens in biorepositories by the addition of genotype or next-generation sequence data. The laboratory specializes in genomic services that cannot be efficiently carried out in individual investigator laboratories. CIDR provides the most up-to-date platforms, services and statistical genetic support. This is an NIH-wide initiative that is managed by NHGRI. Information about current services offered can be accessed via: http://www.cidr.jhmi.edu.

Through WaterSMART, the Bureau of Reclamation (Reclamation) leverages Federal and non-Federal funding to work cooperatively with States, Tribes, and local entities as they plan and implement actions to increase water supply and hydropower reliability. The WaterSMART Program demonstrably advances Trump administration priorities, such as those identified in Presidential Executive Order 14154 (January 20, 2025): Unleashing American Energy (E.O. 14154) and Secretarial Order 3418, and aligns with other priorities and requirements, such as those identified in Presidential Executive Order 14332 (August 7, 2025): Improving Oversight in Federal Grantmaking (E.O. 14332). The goal of the WaterSMART Applied Science Grants (ASG) Notice of Funding Opportunity (NOFO) is to invite eligible entities to apply for funding to improve access to and use of hydrologic data, develop and improve water management tools, and improve hydrologic modeling and forecasting capabilities.Water managers and reservoir operators rely on hydrologic data, modeling, and water supply forecasts to make decisions to meet future water demands. Water supply forecasts are estimates of current and future water supplies based on measured basin conditions (e.g., such as the quantity of upstream mountain snowpack). Results from these projects will be used by water managers to increase water supply reliability to meet water delivery requirements (e.g., compacts, decrees, etc.), provide flexibility in water operations to be more resilient during droughts, and enhance water supply forecasts to better predict floods and optimi...

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Era of Hope Scholar Award supports individuals who are early in their careers with significant potential to effect meaningful change in breast cancer. As the Intent of the FY26 BCRP Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the award’s central features include the Principal Investigator’s (PI’s) demonstrated ability to go beyond conventional thinking in their field and the innovative and meaningful contributions that they can make toward ending breast cancer. The Era of Hope Scholar Award requires exceptionally talented scientists that are among “the best and the brightest” in their field(s), with demonstrated experience forming effective partnerships and collaborations and strong potential for future leadership in breast cancer research. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.Distinctive Features:·        The PI must commit a minimum of 25% level of time and effort during the period of performance to conduct breast cancer research under this award.·        The research team must include two or more breast cancer consumer advocates.

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.Distinctive Features:·        The research team must include two or more breast cancer consumer advocates.·        This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and  Partnering PI) applications by the deadline may result in administrative withdrawal.

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2.Distinctive Features:·        This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance.·        This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.